Global Pediatric Vaccine Market By Vaccine Type (Monovalent, Multivalent), Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, Other Technologies), Application (Infectious Disease, Cancer, Allergy, Other)
Market Analysis: Global Pediatric Vaccine Market
Global pediatric vaccine market is registering a healthy CAGR of 10.1% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in the market can be attributed to increasing awareness and advancements in the vaccines and funding in R&D.
Get Exclusive Sample Report: @
Market Definition: Global Pediatric Vaccine Market
Vaccines are produced with components that render your baby safety and are efficient against illness. Each vaccine includes a small amount of illness germ (viral or bacterium) or germ elements. Examples include pertussis (whooping pneumonia) viruses, measles virus and tetanus toxoid. These vaccines do not trigger disease because the germs are either deceased or strengthened, and the toxoids are also dormant. Vaccines make your child’s immune system easier to protect against illness.
- Significance and awareness of security against the burden of chronic diseases is propelling the growth of the market
- Technological advances in vaccines is boosting the growth of the market
- Boost in government and non-government R&D funding is contributing to the growth of the market
- High prevalence of chronic diseases is driving the growth of the market
- Cost of immunization is very high is hampering the growth of the market
- Limited healthcare and high reliability is hindering the growth of the market
- The difficulties connected with the growth, transport and management of vaccines is hampering the growth of the market
Get Speak To Analyst @
Segmentation: Global Pediatric Vaccine Market
By Vaccine Type
- Live Attenuated
- Infectious Disease
Key Developments in the Market:
In July 2019, X-Vax Technology announced that it has invested $56 million in Series A finance with the involvement of corporate and institutional investors, including Johnson & Johnson Innovation, Adjuvant Capital (a trust equity company backed by the Bill & Melinda Gates Foundation as an affiliate dealer), Serum Institute of India, Alexandria Venture Investments and FF DSF VI (an equity scout from the Founders Fund). Revenue from the funding will be used to promote the X-VAX guide program, the herpes vaccine applicant, known as delta gD-for further growth and manufacturing, including a stage 1 clinical study.
In May 2019, AveXis, a company of Novartis, has announced innovative access programs for Zolgensma for the therapy of pediatric clients less than 2 years of age with bi-allelic SMA mutations in the preservation of the motor nerve cell one (SMN1) chromosome. AveXis works tightly with payers to provide pay-over-time decisions for up to 5 years and results-based contracts for up to 5 years, as well as to provide a hospital program to promote affordability and access.
Global Pediatric Vaccine Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Pediatric Vaccine Market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research